New heart valve device aims to fix tricuspid disease

NCT ID NCT02397668

Recruiting now Disease control Sponsor: Corvivo Cardiovascular, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests a new device called the CorMatrix Cor TRICUSPID ECM Valve to replace a diseased tricuspid valve in the heart. The trial involves 78 people who need valve surgery, including those with congenital heart disease. The goal is to see if the device is safe and works well.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CorMatrix Cor TRICUSPID ECM Valve (a device made from natural material to replace the tricuspid heart valve)
What this could lead to: If successful, this could provide a safe and effective option for replacing a diseased tricuspid valve, potentially improving heart function and quality of life.
What could go wrong: This is a pivotal study, but the device is still being tested for safety and effectiveness. Risks include procedure-related complications or the device not performing as intended.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID VALVE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

tricuspid valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRICUSPID VALVE DISEASE

Contacts and locations

Locations

Cincinnati Children's Hospital
RECRUITING

Cincinnati, Ohio, 45229, United States
Medstar
RECRUITING

Baltimore, Maryland, 21244, United States
Springhill Memorial Hospital
RECRUITING

Mobile, Alabama, 36607, United States
St Francis Hospital
RECRUITING

Indianapolis, Indiana, 46237, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.